Tryn Stimart serves as Executive at AbCellera Biologics Inc., where they oversee executive responsibilities. Since joining the company, Tryn Stimart has executed 6 insider transactions totaling $25.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 1, 2026 involved receiving (via award) 539,265 shares valued at $0.
Tryn Stimart currently holds 4,646,012 shares of AbCellera Biologics Inc. (ABCL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tryn Stimart has been a net seller of ABCL stock. They have purchased $10.0K and sold $25.5M worth of shares.
Tryn Stimart's most recent insider trade was on Jan 1, 2026, when they sold 539,265 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $25.50 |
| Discretionary |
| Jun 7, 2021 | ABCL | $240.0K | Option Exercise | 750,000 | $0.32 | Discretionary |
| Jun 7, 2021 | ABCL | $575.0K | Option Exercise | 250,000 | $2.30 | Discretionary |
| Dec 15, 2020 | ABCL | $5.0K | Purchase | 250 | $20.00 | Discretionary |
| Dec 15, 2020 | ABCL | $5.0K | Purchase | 250 | $20.00 | Discretionary |